HLA-I molecules bind short peptides and present them for recognition by CD8 <sup>+</sup> T cells. The length of HLA-I ligands typically ranges from 8 to 12 aa, but variability is observed across different HLA-I alleles. In this study we collected recent in-depth HLA peptidomics data, including 12 newly generated HLA peptidomes (31,896 unique peptides) from human meningioma samples, to analyze the peptide length distribution and multiple specificity across 84 different HLA-I alleles. We observed a clear clustering of HLA-I alleles with distinct peptide length distributions, which enabled us to study the structural basis of peptide length distributions and predict peptide length distributions from HLA-I sequences. We further iden...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
AbstractBackground: Polymorphism among class I molecules of the major histocompatibility complex (MH...
Background: Class II Major Histocompatibility Complex (MHC) molecules have an open-ended binding gro...
HLA class I-binding predictions are widely used to identify candidate peptide targets of human CD8+ ...
The major ligands presented by MHC class I molecules after natural antigen processing are peptides o...
The major ligands presented by MHC class I molecules after natural antigen processing are peptides o...
The major ligands presented by MHC class I molecules after natural antigen processing are peptides o...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
<div><p>The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
AbstractBackground: Polymorphism among class I molecules of the major histocompatibility complex (MH...
Background: Class II Major Histocompatibility Complex (MHC) molecules have an open-ended binding gro...
HLA class I-binding predictions are widely used to identify candidate peptide targets of human CD8+ ...
The major ligands presented by MHC class I molecules after natural antigen processing are peptides o...
The major ligands presented by MHC class I molecules after natural antigen processing are peptides o...
The major ligands presented by MHC class I molecules after natural antigen processing are peptides o...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
<div><p>The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
AbstractBackground: Polymorphism among class I molecules of the major histocompatibility complex (MH...
Background: Class II Major Histocompatibility Complex (MHC) molecules have an open-ended binding gro...